Medigen Vaccine Biologics (ROCO:6547) E10: NT$-1.79 (As of Dec. 2025)


ROCO:6547 Medigen Vaccine Biologics Corp ROCO:6547
68 GF Score
Price NT$45.45
GF Value NT$69.82
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Medigen Vaccine Biologics E10?

Medigen Vaccine Biologics ROCO:6547 -3.71% 68 E10 is NT$-1.79 as of Dec. 2025. GuruFocus rates ROCO:6547 with a GF Score™ of 68/100 and a GF Value™ of NT$69.82 (Possible Value Trap). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medigen Vaccine Biologics's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$-0.420. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$-1.79 for the trailing ten years ended in Dec. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-01), Medigen Vaccine Biologics's current stock price is NT$45.45. Medigen Vaccine Biologics's E10 for the quarter that ended in Dec. 2025 was NT$-1.79. Medigen Vaccine Biologics's Shiller PE Ratio of today is .


Medigen Vaccine Biologics  (ROCO:6547) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medigen Vaccine Biologics E10 Related Terms


Medigen Vaccine Biologics E10 Historical Data

* Premium members only.

The historical data trend for Medigen Vaccine Biologics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medigen Vaccine Biologics E10 Chart

Medigen Vaccine Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.85 -1.79

Medigen Vaccine Biologics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.85 -1.83 -1.82 -1.79 -1.79

ROCO:6547 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Medigen Vaccine Biologics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigen Vaccine Biologics Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Vaccine Biologics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medigen Vaccine Biologics's Shiller PE Ratio falls into.


ROCO:6547
68GF Score
Medigen Vaccine Biologics Corp ROCO:6547
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medigen Vaccine Biologics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medigen Vaccine Biologics's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.42/324.0540*324.0540
=-0.420

Current CPI (Dec. 2025) = 324.0540.

Medigen Vaccine Biologics Quarterly Data

per share eps CPI Adj_EPS
201512 0.000 236.525 0.000
201606 0.000 241.018 0.000
201609 -0.183 241.428 -0.246
201612 -0.503 241.432 -0.675
201703 -0.366 243.801 -0.486
201706 -0.431 244.955 -0.570
201709 -0.385 246.819 -0.505
201712 -0.542 246.524 -0.712
201803 -0.431 249.554 -0.560
201806 -0.561 251.989 -0.721
201809 -0.385 252.439 -0.494
201812 -0.709 251.233 -0.915
201903 -0.586 254.202 -0.747
201906 -0.685 256.143 -0.867
201909 -0.544 256.759 -0.687
201912 -0.826 256.974 -1.042
202003 -0.504 258.115 -0.633
202006 -0.625 257.797 -0.786
202009 -0.659 260.280 -0.820
202012 -0.638 260.474 -0.794
202103 -0.497 264.877 -0.608
202106 -0.566 271.696 -0.675
202109 2.120 274.310 2.504
202112 3.364 278.802 3.910
202203 -0.440 287.504 -0.496
202206 -0.960 296.311 -1.050
202209 -0.950 296.808 -1.037
202212 -2.210 296.797 -2.413
202303 -0.650 301.836 -0.698
202306 -0.960 305.109 -1.020
202309 -0.160 307.789 -0.168
202312 -1.772 306.746 -1.872
202403 -0.220 312.332 -0.228
202406 0.040 314.175 0.041
202409 0.005 315.301 0.005
202412 -0.060 315.605 -0.062
202503 -0.060 319.799 -0.061
202506 -0.300 322.561 -0.301
202509 -0.070 324.800 -0.070
202512 -0.420 324.054 -0.420

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$-1.79 mean?
Medigen Vaccine Biologics (ROCO:6547) has a E10 of NT$-1.79 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medigen Vaccine Biologics and its competitors.
Is Medigen Vaccine Biologics' E10 too high?
Medigen Vaccine Biologics' current E10 is NT$-1.79. Overall, Medigen Vaccine Biologics has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medigen Vaccine Biologics' E10 compare to VRTX and REGN?
Medigen Vaccine Biologics' E10 of NT$-1.79 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medigen Vaccine Biologics and its competitors. Medigen Vaccine Biologics's current E10 is NT$-1.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigen Vaccine Biologics stock overvalued right now?
Based on GuruFocus' analysis, Medigen Vaccine Biologics (ROCO:6547) is currently considered Possible Value Trap. The stock's GF Value™ is NT$69.82, compared to a current price of NT$45.45 — trading 34.9% below its estimated fair value. The current E10 is NT$-1.79. Medigen Vaccine Biologics' overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Medigen Vaccine Biologics (ROCO:6547), the current E10 is NT$-1.79 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medigen Vaccine Biologics (ROCO:6547) Overvalued in 2026?

Based on GuruFocus' analysis, Medigen Vaccine Biologics stock appears to be undervalued. The current stock price of NT$45.45 is trading 34.9% below its estimated GF Value™ of NT$69.82. GuruFocus considers Medigen Vaccine Biologics to be Possible Value Trap.

Key valuation signals for ROCO:6547:

  • E10: NT$-1.79
  • GF Value™: NT$69.82 vs. price of NT$45.45 (34.9% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medigen Vaccine Biologics Business Description

Address 302 No. 68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261
Medigen Vaccine Biologics Corp is engaged in the research, development and wholesale of vaccine and biopharmaceutical, medical devices wholesale and retail, etc. Its products include dengue vaccine, anti-RSV biosimilars, COVID-19 vaccines, enterovirus A71 vaccine, and influenza vaccine QIZ. It operates business only in a single industry in Taiwan.
68GF Score

Get the complete analysis for ROCO:6547

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$45.45
Price
NT$69.82
GF Value